Profile data is unavailable for this security.
About the company
Atomo Diagnostics Limited is an Australia-based medical device company. The Company supplies integrated rapid diagnostic test (RDT) devices to the global diagnostic market. The Company’s patented devices simplify testing procedures, enhance usability and improve reliability across rapid point-of-care (POC) and at-home testing applications. The Company has commercialized a number of products across international markets and has supply agreements in place for testing applications targeting infectious diseases, including COVID-19, HIV, viral vs bacterial differentiations as well as the early detection of pregnancy. Its products include Atomo HIV Self-Test, AtomoRapid Pascal and AtomoRapid Curie, among others. Its Atomo HIV Self-Test is an integrated, blood-based rapid diagnostic test (RDT) for HIV screening, which provides results in 15 minutes. The AtomoRapid Pascal platform offers improved performance and usability in point of care testing.
- Revenue in AUD (TTM)4.24m
- Net income in AUD-6.85m
- Incorporated2010
- Employees--
- LocationAtomo Diagnostics LtdLevel 1, 3-5 George Street, LeichhardtSYDNEY 2040AustraliaAUS
- Phone+61 29099-4750
- Websitehttps://www.atomodiagnostics.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adherium Ltd | 2.29m | -10.22m | 7.59m | -- | -- | 1.13 | -- | 3.31 | -0.0275 | -0.0275 | 0.0062 | 0.0089 | 0.2031 | 1.05 | 1.22 | -- | -90.61 | -110.82 | -129.82 | -157.56 | 35.33 | 49.25 | -446.19 | -413.92 | 2.43 | -- | 0.0142 | -- | -54.47 | -4.27 | -3.71 | -- | -83.48 | -- |
| Visioneering Technologies Inc | 13.39m | -5.39m | 7.71m | -- | -- | 1.14 | -- | 0.5755 | -0.122 | -0.122 | 0.295 | 0.1224 | 1.21 | 2.08 | 7.06 | -- | -48.75 | -76.38 | -75.48 | -97.70 | 56.74 | 44.90 | -40.22 | -98.70 | 2.44 | -- | 0.00 | -- | 19.01 | 21.36 | 41.05 | -- | -- | -- |
| Inhalerx Ltd | 891.64k | -756.82k | 8.02m | -- | -- | -- | -- | 9.00 | -0.004 | -0.004 | 0.0047 | -0.0003 | 1.05 | -- | 2.81 | -- | -88.94 | -80.34 | -252.07 | -99.88 | -- | -- | -84.88 | -500.13 | -- | -11.57 | 1.19 | -- | 2,226.09 | 22.79 | 25.10 | -- | -- | -- |
| Global Health Limited | 8.67m | -1.31m | 8.13m | 49.00 | -- | -- | -- | 0.9377 | -0.0226 | -0.0226 | 0.1493 | -0.05 | 2.80 | -- | 11.81 | -- | -42.35 | -34.67 | -- | -112.41 | 81.18 | 78.53 | -15.14 | -32.95 | -- | -12.78 | -- | -- | 10.86 | 9.42 | 83.71 | -- | -55.12 | -- |
| Memphasys Ltd | 60.00k | -4.44m | 8.82m | 24.00 | -- | 1.01 | -- | 146.92 | -0.004 | -0.004 | 0.00005 | 0.005 | 0.0044 | 0.3952 | -- | -- | -32.78 | -19.51 | -54.58 | -25.22 | 2.67 | -- | -7,403.38 | -12,238.50 | 0.2767 | -13.90 | 0.4104 | -- | 290.37 | -- | -30.55 | -- | -21.39 | -- |
| Uscom Ltd | 3.77m | -2.07m | 11.27m | 11.00 | -- | 3.60 | -- | 2.99 | -0.0118 | -0.0118 | 0.0214 | 0.0125 | 0.7316 | 0.8874 | 11.28 | -- | -40.23 | -30.60 | -53.05 | -36.97 | 83.80 | 86.20 | -54.99 | -53.50 | 2.54 | -17.76 | 0.2443 | -- | 38.73 | 0.9977 | 19.92 | -- | -12.44 | -- |
| Atomo Diagnostics Ltd | 4.24m | -6.85m | 13.42m | -- | -- | 1.33 | -- | 3.17 | -0.0108 | -0.0108 | 0.0067 | 0.0158 | 0.3044 | 1.25 | 3.09 | -- | -49.17 | -31.42 | -54.41 | -34.20 | 41.48 | 42.58 | -161.56 | -120.99 | 4.84 | -- | 0.0083 | -- | 66.63 | 51.01 | 31.23 | -- | -54.38 | -- |
| Control Bionics Ltd | 5.97m | -5.91m | 16.34m | -- | -- | 2.10 | -- | 2.74 | -0.0381 | -0.0381 | 0.0374 | 0.0315 | 0.6732 | 2.41 | 2.98 | -- | -66.73 | -41.07 | -85.40 | -45.97 | 75.62 | 68.78 | -99.13 | -92.33 | 1.40 | -112.62 | 0.133 | -- | 2.08 | 46.24 | -5.02 | -- | 67.72 | -- |
| Resonance Health Ltd | 8.80m | 169.31k | 17.47m | 18.00 | 111.76 | 1.55 | 26.17 | 1.98 | 0.0003 | 0.0003 | 0.0188 | 0.0245 | 0.5631 | -- | 5.08 | -- | 1.08 | -3.19 | 1.40 | -3.56 | -- | -- | 1.92 | -7.63 | -- | -- | 0.2527 | -- | 95.15 | 19.18 | 121.70 | -33.17 | 1.63 | -- |
| Singular Health Group Ltd | 945.75k | -2.88m | 18.82m | -- | -- | 12.35 | -- | 19.89 | -0.018 | -0.0308 | 0.0063 | 0.0074 | 0.3536 | 8.73 | 22.14 | -- | -107.62 | -- | -331.71 | -- | 124.56 | -- | -304.36 | -- | 2.42 | -- | 0.1316 | -- | 112.26 | -- | 42.12 | -- | -- | -- |
| ImExHS Ltd | 24.68m | -3.42m | 19.05m | 400.00 | -- | 1.26 | -- | 0.7718 | -0.0794 | -0.0794 | 0.5713 | 0.3314 | 1.10 | 97.11 | 3.78 | 61,692.52 | -15.28 | -22.17 | -20.83 | -29.21 | 31.95 | 29.75 | -13.85 | -31.20 | 1.53 | -4.58 | 0.0593 | -- | 14.79 | 26.48 | -37.97 | -- | 5.61 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Ellerston Capital Ltd.as of 15 Mar 2023 | 42.74m | 6.69% |
